Thermo Fisher Scientific Inc (TMO)
513.26
-2.84
(-0.55%)
USD |
NYSE |
Nov 22, 16:00
516.70
+3.44
(+0.67%)
After-Hours: 20:00
Thermo Fisher Scientific Market Cap: 196.32B for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 196.32B |
| November 21, 2024 | 197.41B |
| November 20, 2024 | 196.16B |
| November 19, 2024 | 194.74B |
| November 18, 2024 | 191.74B |
| November 15, 2024 | 196.25B |
| November 14, 2024 | 203.88B |
| November 13, 2024 | 207.28B |
| November 12, 2024 | 206.84B |
| November 11, 2024 | 209.20B |
| November 08, 2024 | 211.04B |
| November 07, 2024 | 212.63B |
| November 06, 2024 | 214.08B |
| November 05, 2024 | 214.50B |
| November 04, 2024 | 212.47B |
| November 01, 2024 | 213.40B |
| October 31, 2024 | 208.97B |
| October 30, 2024 | 210.61B |
| October 29, 2024 | 209.52B |
| October 28, 2024 | 211.35B |
| October 25, 2024 | 212.05B |
| October 24, 2024 | 213.20B |
| October 23, 2024 | 220.51B |
| October 22, 2024 | 224.29B |
| October 21, 2024 | 227.73B |
| Date | Value |
|---|---|
| October 18, 2024 | 230.15B |
| October 17, 2024 | 229.21B |
| October 16, 2024 | 226.27B |
| October 15, 2024 | 229.70B |
| October 14, 2024 | 230.95B |
| October 11, 2024 | 228.32B |
| October 10, 2024 | 227.12B |
| October 09, 2024 | 229.21B |
| October 08, 2024 | 227.76B |
| October 07, 2024 | 229.06B |
| October 04, 2024 | 228.97B |
| October 03, 2024 | 229.85B |
| October 02, 2024 | 234.37B |
| October 01, 2024 | 234.45B |
| September 30, 2024 | 236.60B |
| September 27, 2024 | 234.71B |
| September 26, 2024 | 236.58B |
| September 25, 2024 | 229.11B |
| September 24, 2024 | 233.74B |
| September 23, 2024 | 233.15B |
| September 20, 2024 | 234.43B |
| September 19, 2024 | 236.93B |
| September 18, 2024 | 233.06B |
| September 17, 2024 | 233.20B |
| September 16, 2024 | 234.60B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
101.82B
Minimum
Mar 23 2020
263.18B
Maximum
Dec 31 2021
198.64B
Average
207.28B
Median
Market Cap Benchmarks
| Fonar Corp | 105.20M |
| XWELL Inc | 7.884M |
| ProPhase Labs Inc | 18.36M |
| Applied DNA Sciences Inc | 1.596M |
| Veracyte Inc | 3.068B |
Market Cap Related Metrics
| PE Ratio | 32.18 |
| PS Ratio | 4.661 |
| PEG Ratio | 7.117 |
| Price to Book Value | 4.007 |
| Price to Free Cash Flow | 25.40 |
| Price | 513.26 |
| Earnings Yield | 3.11% |
| PEGY Ratio | 6.679 |
| Operating PE Ratio | 26.66 |
| Normalized PE Ratio | 31.09 |